ISRCTN10011099
Completed
未知
A single-centre, two-arm, controlled, prospective randomized trial comparing standard crepe bandaging with Andoflex TLC Calamine Lite (25-30 mmHg) compression bandaging after knee surgery
orth Cumbria Integrated Care NHS Foundation Trust0 sites122 target enrollmentNovember 17, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Knee surgery
- Sponsor
- orth Cumbria Integrated Care NHS Foundation Trust
- Enrollment
- 122
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2024 Results article in https://doi.org/10.1016/j.ijotn.2024.101100 (added 09/04/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient who is listed for:
- •1\.1\. Knee arthroplasty (replacement) surgery, either partial or total knee replacement (single or double)
- •1\.2\. Unilateral high tibial osteotomy (HTO) or distal femoral osteotomy (DFO) or a double osteotomy (HTO and DFO) at one of participating NHS Trusts
- •1\.3, In case of double procedure patients, one leg will be classed as the index leg and all outcomes measures will focus on said leg
- •2\. Clinical indication, in the opinion of the treating surgeon, that dual\-layer compression bandaging may be of benefit to the patient
- •3\. Adult patients aged \>18 years
- •4\. Mental capacity to give written informed consent
Exclusion Criteria
- •1\. Under the age of 18 years
- •2\. Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity
- •3\. Revision of previous knee replacement or osteotomy on the index leg
- •4\. Limited life expectancy, i.e. undergoing palliative care
- •5\. Any condition that is associated with excessive bleeding, coagulation abnormalities or any other significant haematological condition (e.g. Factor V Leiden, haemophilia)
- •6\. Cardiovascular or vascular condition that in the opinion of the treating surgeon contraindicates the use of compression bandaging, including moderate to severe peripheral arterial disease, venous leg ulcer, high dose anti\-coagulant medication
- •7\. Any skin or other condition that contraindicates the use of compression bandaging, including diabetic foot ulcer or peripheral neuropathy
- •8\. Patients who are participating in another interventional research study involving an investigational product related to the knee procedure and its aftercare
- •9\. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the WOUNDCHEK point-of-care test for infection in the management of foot and leg ulcersChronic ulcer wounds of the legs and feetSkin and Connective Tissue DiseasesISRCTN11300898orth Cumbria Integrated Care NHS Foundation Trust131
Completed
Phase 1
A study to compare how the body processes first and second generation RO7490677 (recombinant human pentraxin-2; rhPTX-2) drug products in healthy participantsISRCTN59409907F. Hoffmann-La Roche Ltd44
Completed
Not Applicable
Reported Outcomes for Bandaging after Osteotomy TrialHigh tibial osteotomySurgeryISRCTN15376709Cumbria Partnership NHS Foundation Trust49
Active, not recruiting
Not Applicable
A pilot study to evaluate automatic deep vein thrombosis diagnostic softwareDeep vein thrombosisCirculatory SystemPhlebitis and thrombophlebitis of other deep vessels of lower extremitiesISRCTN11069056Oxford University Hospitals NHS Trust400
Completed
Phase 1
BUTEO: a clinical trial of BTT1023 in patients with primary sclerosing cholangitis (PSC)ISRCTN11233255niversity of Birmingham23